• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5542386
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
22.83
104587.66
EPS(TTM)
Face Value()
Div & Yield %
56.72
2
1.24
 

cipla ltd
Cipla's Goa unit completes USFDA inspection with two observations
Apr 17,2026
Cipla announced that that the USFDA has conducted an inspection at the Company's manufacturing facility in Verna, Goa from 6 to 17 April 2026. The inspection was a routine current Good Manufacturing Practices (cGMP) inspection and a Pre-Approval Inspection (PAI). On conclusion of the inspection, the Company received two (2) inspectional observations in Form 483.